Definition	O
of	O
pathogens	O

It	O
remains	O
difficult	O
to	O
determine	O
whether	O
the	O
organisms	O
detected	O
by	O
the	O
DNA	O
Detection	O
Kit	O
are	O
true	O
pathogens	O
.	O

This	O
also	O
applies	O
,	O
although	O
to	O
a	O
much	O
lesser	O
degree	O
,	O
to	O
conventional	O
blood	B-Organism_substance
culture	O
analysis	O
.	O

However	O
,	O
detected	O
organisms	O
were	O
considered	O
to	O
be	O
pathogens	O
if	O
the	O
results	O
of	O
culture	O
tests	O
from	O
samples	B-Organism_substance
of	O
the	O
suspected	O
infectious	O
sites	O
coincided	O
with	O
the	O
results	O
of	O
DNA	O
Detection	O
Kit	O
or	O
blood	B-Organism_substance
culture	O
analysis	O
.	O

The	O
culture	O
data	O
of	O
sputum	B-Organism_substance
,	O
urine	B-Organism_substance
,	O
pus	B-Organism_substance
and	O
drainage	O
fluid	B-Organism_substance
were	O
used	O
to	O
define	O
the	O
pathogens	O
.	O

A	O
decision	O
as	O
to	O
whether	O
an	O
identified	O
organism	O
was	O
a	O
pathogen	O
was	O
taken	O
based	O
on	O
the	O
decision	O
tree	O
shown	O
in	O
Figure	O
1	O
.	O

Thus	O
,	O
when	O
the	O
same	O
organism	O
was	O
detected	O
by	O
both	O
DNA	O
Detection	O
Kit	O
and	O
blood	B-Organism_substance
culture	O
analysis	O
,	O
the	O
detected	O
organism	O
was	O
considered	O
an	O
infectious	O
pathogen	O
.	O

If	O
there	O
was	O
a	O
discrepancy	O
between	O
the	O
organism	O
that	O
was	O
detected	O
by	O
SeptiFast	O
analysis	O
and	O
that	O
detected	O
by	O
blood	B-Organism_substance
culture	O
analysis	O
,	O
or	O
if	O
an	O
organism	O
was	O
only	O
detected	O
in	O
one	O
of	O
these	O
tests	O
,	O
then	O
other	O
samples	B-Organism_substance
taken	O
from	O
the	O
infection	O
site	O
were	O
analyzed	O
.	O

If	O
this	O
second	O
culture	O
test	O
of	O
the	O
suspected	O
infectious	O
site	O
revealed	O
the	O
presence	O
of	O
the	O
same	O
organism	O
,	O
this	O
organism	O
was	O
considered	O
to	O
be	O
a	O
pathogen	O
.	O

If	O
the	O
microbial	O
strain	B-Cell
was	O
only	O
detected	O
once	O
for	O
a	O
sample	B-Organism_substance
,	O
we	O
then	O
checked	O
the	O
second	O
culture	O
results	O
in	O
the	O
suspected	O
infectious	O
sites	O
.	O

If	O
this	O
result	O
identified	O
the	O
same	O
strain	B-Cell
as	O
that	O
identified	O
by	O
SeptiFast	O
analysis	O
then	O
it	O
was	O
decided	O
that	O
this	O
strain	B-Cell
was	O
a	O
pathogen	O
.	O

However	O
,	O
if	O
the	O
strain	B-Cell
was	O
still	O
only	O
detected	O
in	O
some	O
of	O
the	O
assays	O
,	O
we	O
next	O
determined	O
if	O
the	O
patient	O
involved	O
suffered	O
from	O
sepsis	O
.	O

Sepsis	O
is	O
defined	O
as	O
SIRS	O
caused	O
by	O
infection	O
.	O

The	O
definition	O
of	O
sepsis	O
that	O
we	O
used	O
was	O
based	O
on	O
the	O
International	O
Sepsis	O
Forum	O
Definition	O
of	O
Infection	O
at	O
the	O
ICU	O
Consensus	O
Conference	O
[	O
7	O
]	O
.	O

However	O
,	O
if	O
the	O
underlying	O
disease	O
is	O
acute	B-Cancer
lymphoma	I-Cancer
leukemia	I-Cancer
(	O
ALL	B-Cancer
)	O
,	O
malignant	B-Cancer
lymphoma	I-Cancer
(	O
ML	B-Cancer
)	O
,	O
or	O
acute	B-Cancer
myelogenous	I-Cancer
leukemia	I-Cancer
(	O
AML	B-Cancer
)	O
,	O
the	O
definition	O
of	O
infection	O
is	O
defined	O
as	O
the	O
ability	O
to	O
detect	O
infectious	O
organisms	O
by	O
blood	B-Organism_substance
culture	O
analysis	O
.	O

If	O
the	O
patient	O
was	O
not	O
defined	O
as	O
having	O
sepsis	O
when	O
whole	B-Organism_substance
blood	I-Organism_substance
was	O
administered	O
to	O
the	O
patient	O
,	O
we	O
decided	O
that	O
the	O
strain	B-Cell
detected	O
by	O
subsequent	O
DNA	O
Detection	O
Kit	O
or	O
blood	B-Organism_substance
culture	O
analysis	O
was	O
not	O
a	O
pathogen	O
.	O

Figure	O
1	O

Flowchart	O
for	O
pathogen	O
decision	O
.	O

Samples	B-Organism_substance
were	O
defined	O
as	O
negative	O
for	O
pathogens	O
if	O
a	O
pathogen	O
could	O
not	O
be	O
detected	O
by	O
any	O
method	O
of	O
analysis	O
within	O
seven	O
days	O
,	O
and	O
if	O
another	O
type	O
of	O
culture	O
test	O
did	O
not	O
detect	O
this	O
pathogen	O
but	O
could	O
detect	O
other	O
organisms	O
.	O

CoNS	O
bacteria	O
,	O
which	O
are	O
represented	O
by	O
the	O
Staphylococcus	O
epidermidis	O
(	O
S	O
.	O
epidermidis	O
)	O
and	O
Streptococcus	O
spp	O
.	O
are	O
indigenous	O
bacteria	O
and	O
often	O
cause	O
contamination	O
in	O
assays	O
of	O
pathogens	O
.	O

Therefore	O
,	O
when	O
CoNS	O
or	O
Streptococcus	O
spp	O
.	O
were	O
detected	O
by	O
blood	B-Organism_substance
culture	O
and	O
SeptiFast	O
analysis	O
,	O
the	O
following	O
criteria	O
were	O
applied	O
to	O
define	O
whether	O
these	O
strains	B-Cell
represented	O
a	O
pathogenic	O
infection	O
:	O
(	O
1	O
)	O
Tests	O
were	O
performed	O
at	O
least	O
twice	O
within	O
48	O
hours	O
before	O
and	O
after	O
CoNS	O
were	O
detected	O
by	O
blood	B-Organism_substance
culture	O
or	O
SeptiFast	O
analysis	O
;	O
(	O
2	O
)	O
CoNS	O
or	O
Streptococcus	O
spp	O
.	O
were	O
detected	O
in	O
two	O
different	O
blood	B-Organism_substance
culture	O
tests	O
that	O
were	O
separately	O
performed	O
twice	O
within	O
48	O
hours	O
;	O
and	O
,	O
(	O
3	O
)	O
CoNS	O
or	O
Streptococcus	O
spp	O
.	O
were	O
detected	O
twice	O
or	O
more	O
in	O
tests	O
that	O
were	O
performed	O
three	O
times	O
[	O
11	O
-	O
15	O
]	O
.	O

If	O
a	O
sample	B-Organism_substance
'	O
s	O
results	O
met	O
any	O
of	O
these	O
three	O
criteria	O
,	O
then	O
the	O
sample	B-Organism_substance
was	O
evaluated	O
as	O
a	O
pathogen	O
.	O

The	O
distinction	O
between	O
pathogen	O
and	O
contamination	O
was	O
also	O
determined	O
for	O
CoNS	O
or	O
Streptococcus	O
spp	O
.	O
from	O
the	O
crossing	O
point	O
(	O
Cp	O
)	O
obtained	O
using	O
the	O
LightCycler	O
analysis	O
software	O
v4	O
.	O
05	O
.	O

The	O
Cp	O
represents	O
the	O
point	O
in	O
the	O
amplification	O
cycle	O
where	O
the	O
amplification	O
curve	O
crosses	O
the	O
detection	O
threshold	O
.	O

When	O
CoNS	O
or	O
Streptococcus	O
spp	O
.	O
were	O
detected	O
using	O
the	O
LightCycler	O
analysis	O
software	O
v4	O
.	O
05	O
,	O
a	O
Cp	O
of	O
less	O
than	O
20	O
was	O
defined	O
as	O
indicating	O
a	O
pathogen	O
and	O
a	O
Cp	O
of	O
over	O
20	O
was	O
defined	O
as	O
contamination	O
by	O
checking	O
the	O
amplification	O
curve	O
.	O

